A randomized crossover trial of a wedged insole for treatment of knee osteoarthritis

被引:111
作者
Baker, Kristin
Goggins, Joyce
Xie, Hui
Szumowski, Karen
LaValley, Michael
Hunter, David J.
Felson, David T.
机构
[1] Boston Univ, Sch Med, Boston, MA 02118 USA
[2] Vet Affairs Boston Hlth Care Syst, Boston, MA USA
来源
ARTHRITIS AND RHEUMATISM | 2007年 / 56卷 / 04期
关键词
D O I
10.1002/art.22516
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objective. In uncontrolled studies, a lateral-wedge insole has reduced knee pain in patients with medial knee osteoarthritis (OA). The aim of this study was to test the efficacy of this simple, low-cost intervention for pain in patients with medial knee OA. Methods. We conducted a double-blind, randomized, crossover trial designed to detect a small effect of treatment. Participants were at least 50 years of age and had medial joint space narrowing on posteroanterior semiflexed radiographs and scores indicating moderate pain for 2 of the 5 items on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain scale. Participants were randomized to receive a 5 degrees lateral-wedge insole or a neutral insole for 6 weeks. Following a 4-week washout period, participants crossed over to the other treatment for 6 weeks. Knee pain, the primary outcome, was assessed by the WOMAC pain scale (visual analog scale version). Secondary outcomes included the WOMAC disability subscale, overall knee pain, 50-feet walk time, chair-stand time, and use of medications for knee pain. Results. Ninety patients were randomized. The mean difference in pain between the 2 treatments was 13.8 points on the WOMAC pain scale (95% confidence interval -3.9, 31.4 [P = 0.13]). We observed similar small effects for the secondary outcomes. Conclusion. The effect of treatment with a lateral-wedge insole for knee OA was neither statistically significant nor clinically important.
引用
收藏
页码:1198 / 1203
页数:6
相关论文
共 24 条
[1]
ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3
[2]
ANDRIACCHI TP, 1994, ORTHOP CLIN N AM, V25, P395
[3]
BELLAMY N, 1993, J RHEUMATOL, V20, P999
[4]
BELLAMY N, 1988, J RHEUMATOL, V15, P1833
[5]
BELLAMY N, 1992, J RHEUMATOL, V19, P444
[6]
Ehrich EW, 2000, J RHEUMATOL, V27, P2635
[7]
Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO
[8]
2-9
[9]
Bone marrow edema and its relation to progression of knee osteoarthritis [J].
Felson, DT ;
McLaughlin, S ;
Goggins, J ;
LaValley, MP ;
Gale, E ;
Totterman, S ;
Li, W ;
Hill, C ;
Gale, D .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (05) :330-336
[10]
Felson DT, 2001, ARTHRITIS RHEUM-US, V44, P1477, DOI 10.1002/1529-0131(200107)44:7<1477::AID-ART267>3.0.CO